| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 703 FNMA 7.25% 9/25/22 | 679 | 801 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 5000 Ambase Corp | 7,854 | 10,750 |
| 1000 Clifton Bancorp Inc | 13,219 | 13,650 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| 2500 Navidea Biopharmaceuticals Inc | AT COST | 5,075 | 3,375 |
| 3000 Onconova Therapeutics Inc | AT COST | 33,016 | 6,960 |
| 2000 Synta Pharmaceuticals Inc | AT COST | 10,399 | 4,500 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| Partnership K-1s | -179 | -179 | -179 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| State of New Hampshire | 75 | 0 | 0 | |
| Internal Revenue Service | 9 | 0 | 0 |